Mind Medicine Inc. (NASDAQ:MNMD) commenced trading its subordinate voting shares on The Nasdaq Capital Market Tuesday, under the ticker symbol “MNMD,” as previously announced. The psychedelic medicine biotech company said it will continue to list on the Neo Exchange Inc. under the symbol “MMED,” while subordinate voting shares will transform from the OTCQB under the symbol “MMEDF” to “MNMD.” MindMed will hold a live bell-ringing ceremony Thursday to celebrate the Nasdaq listing. When the company first confirmed last week that it had obtained all the requirements to list on the Nasdaq, CEO and co-founder J.R. Rahn said it's an important milestone in the company's development.